Market Overview

Ortho Dermatologics Announces 2019 Aspire Higher Scholarship Recipients


$10,000 Scholarships Awarded to Nine Students Affected by Dermatologic Conditions

LAVAL, Quebec, Oct. 10, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (TSX:BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the 2019 Aspire Higher scholarship program recipients. The program, which since 2013 has granted more than $648,000 in scholarships to students who have been affected by dermatologic conditions, will award nine students with scholarships of $10,000 each to pursue their undergraduate or graduate degrees.

"Through the Aspire Higher program, we've heard firsthand from students across the country about the challenges that often come with dermatologic conditions," said Bill Humphries, president,
Ortho Dermatologics. "This year's honorees are an inspiration for how they've faced these challenges and are a testament to the far-reaching impact dermatologists have when they help their patients resolve or manage skin conditions. We are proud to support these students with scholarships that will help them achieve their educational goals."

The 2019 honorees were selected from nearly 1,400 applications, based in part on essays sharing their experiences pursuing their education while living with a dermatologic condition. In these essays, applicants also shared the role their dermatologist, primary care physician, physician assistant or nurse practitioner played in helping them reach their goals. The applications were judged by an independent panel of dermatologists from across the country.

"Through my time serving on the judging panel of the Aspire Higher program, applicants continue to inspire me with their dedication to excel personally and academically," said Adelaide A. Hebert, MD, dermatologist at UT Physicians Dermatology at Texas Medical Center, Houston, TX. "Each application reminds me of why I am proud to be part of both the dermatology community and this initiative with Ortho Dermatologics, which gives students who have struggled with a skin condition a helping hand in achieving their academic aspirations."

The Aspire Higher program recognizes students across a wide range of educational pursuits, with scholarships in three categories, including the Undergraduate Scholar Awards for those pursuing undergraduate degrees, the Graduate Scholar Awards for those pursuing graduate degrees, and the Today's Woman Scholar Awards for mothers pursuing undergraduate or graduate degrees.

The 2019 Aspire Higher recipients are:

  • Undergraduate Scholar Award
    • Kayla Scott, Esmont, VANorth Carolina A&T State University
    • Robin Cadd, Sierra Madre, CAUniversity of Southern California
    • Stephanie Pham, Temecula, CAArizona State University
  • Graduate Scholar Award
    • Astrid Guevara, Baytown, TXUniversity of Pittsburgh School of Medicine
    • Maura Vrabel, Raleigh, NCUniversity of North Carolina at Chapel Hill School of Medicine and North Carolina State University College of Engineering
    • Saiaditya Badeti, Plainsboro, NJ – Rutgers New Jersey Medical School
  • Today's Woman Scholar Award
    • Caitlin Sanner, Wellington, COFront Range Community College
    • Camilla Marshall, Bowie, MDJohns Hopkins University
    • Marissa Hunter, Vancouver, WACalifornia Baptist University

"Thanks to this scholarship, I can now turn my experience with a painful skin disease into something positive and help others who are suffering through similar issues," said Astrid Guevara, a 2019 Aspire Higher Graduate Scholar student at the University of Pittsburgh School of Medicine. "I can focus less on paying for medical school and more on becoming the best physician I can be for my patients and their families."

To learn more about the Aspire Higher scholarship, please visit The 2020 Aspire Higher scholarship program will begin accepting applications in early 2020.

About Aspire Higher and Other Philanthropic Initiatives
Since 2013, the Aspire Higher scholarship program has awarded 42 scholarships, providing students a total of more than $648,000 toward their higher education on campuses nationwide. The Aspire Higher Scholarship program is funded through the Bausch Foundation, which was established in 2017 to improve the lives of patients globally by providing access to safe, effective medicines and by financially supporting health care education and causes around the world. In addition to Aspire Higher, Ortho Dermatologics, through the Bausch Foundation, supports the Children's Skin Disease Foundation's Camp Wonder.

About Ortho Dermatologics
Ortho Dermatologics is one of the largest prescription dermatology businesses dedicated to helping patients in the treatment of a range of therapeutic areas, including psoriasis, actinic keratosis, acne, atopic dermatitis and other dermatoses. The Ortho Dermatologics portfolio includes several leading acne, anti-fungal and corticosteroid-responsive dermatoses products. More information can be found at

About Bausch Health
Bausch Health Companies Inc. (TSX:BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at

Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in the Company's most recent annual or quarterly report and detailed from time to time in the Company's other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. In addition, certain material factors and assumptions have been applied in making these forward-looking statements, including that the risks and uncertainties outlined above will not cause actual results or events to differ materially from those described in these forward-looking statements. The Company believes that the material factors and assumptions reflected in these forward-looking statements are reasonable, but readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Ortho Dermatologics is a trademark of Ortho Dermatologics' affiliated entities.
© 2019 Ortho Dermatologics' affiliated entities.

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

(514) 856-3855

(908) 927-1198

(877) 281-6642 (toll free)


Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)


(PRNewsfoto/Valeant Pharmaceuticals Interna)

Cision View original content to download multimedia:

SOURCE Bausch Health Companies Inc.

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at